Skip to main content
Equibles

Groupe la Francaise

Position in RNA — Atrium Therapeutics, Inc.

CIK 2056088 PARIS, I0
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 25, 2026
Position Value
$1,079,671
+$682,609 QoQ
Shares Held
80,273
+170.3% QoQ
Ownership
0.469%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#46
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Groupe la Francaise holds $13,850,146 across 9 Biotechnology names. RNA ranks #2 (7.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 APGE
Apogee Therapeutics, Inc.
 84,072 $11,158,876
2 RNA
Atrium Therapeutics, Inc.
This page 		80,273 $1,079,671
3 TBPH
Theravance Biopharma, Inc.
 30,000 $510,000
4 BNTX
BioNTech SE
 4,200 $390,810
5 MRNA
Moderna, Inc.
 5,053 $353,861
6 REGN
Regeneron Pharmaceuticals, Inc.
 553 $344,817
7 RPRX
Royalty Pharma plc
 216 $12,111
8
256,497 $0

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,079,671 80,273
2026-03-31 $397,062 29,698